Genomcore

About Genomcore

Genomcore, founded in 2015 by Oscar Flores Guri and Miquel Àngel Bru, is a health-tech company headquartered in Barcelona, Spain. The founders' combined expertise in science, technology, healthcare, and business has established the firm as a key player in precision medicine solutions. Genomcore has raised a total of $6.27 million over four funding rounds, with its latest Series A round in December 2024 raising €5 million, led by QVIDTVM and including strategic investment from Barça Innovation Hub (BIHUB).

The company operates on a business-to-business (B2B) model, providing its platform and services to clients across the biohealth industry. These clients include clinical laboratories, pharmaceutical companies, contract research organizations (CROs), diagnostics providers, healthcare professionals, and government entities. Genomcore's core offering is its Biomedical Information Management System (BIMS), a low-code, modular platform designed to manage and analyze large, complex health datasets. This system addresses the challenges of data interoperability, security, and scalability in the healthcare sector.

The BIMS platform features a unified multimodal datastore that integrates diverse data types such as genomics, medical imaging, clinical data, and information from wearables. It supports the entire genomics workflow, from pre-analytical requests to post-analytical reporting for various methods like NGS, PCR, and arrays. The platform is built on Kubernetes, allowing for scalable and secure deployment across cloud, on-premises, or hybrid environments. It is compliant with major regulatory standards, including GDPR and HIPAA. A key feature is the App Platform & Marketplace, which allows clients to use pre-built tools or develop their own custom applications for data analysis, AI model training, and more. The company has also developed a spin-off called Made of Genes, which uses the BIMS infrastructure for personalized health by cross-referencing DNA with blood biomarkers and lifestyle data.

Genomcore has established several significant partnerships and has been chosen for major projects. In April 2025, the company announced a strategic alliance with Illumina, a global leader in DNA sequencing, to advance infrastructure for multi-omic data management. The collaboration with FC Barcelona's BIHUB aims to centralize the club's biomedical data to optimize player performance and prevent injuries. Genomcore is also involved in national-level projects, such as Medigenomics for the Madrid Public Healthcare Service and SIGenES, a project to create a nationwide genomic information-sharing network for Spain's National Health System.